Table 4.
Breast Muscle | Thigh Muscle | |||||
---|---|---|---|---|---|---|
Group * | AlaAP | LeuAP | ArgAP | AlaAP | LeuAP | ArgAP |
100S | 888.7 ± 11.1 | 130.0 ± 1.5 | 905.6 ± 10 | 909.7 ± 39.6 | 384.1 ± 13.9 | 926.9 ± 36.7 |
100N | 890.8 ± 22.2 | 141.9 ± 6.1 | 913.3 ± 15.1 | 895.0 ± 63.6 | 359.3 ± 43.9 | 906.8 ± 67.8 |
50S | 885.2 ± 21.9 | 139.5 ± 5.4 | 913.4 ± 16.6 | 856.7 ± 58.8 | 287.5 ± 24.5 | 813.8 ± 61.3 |
50N | 897.3 ± 7.04 | 148.2 ± 7.4 | 908.4 ± 9.8 | 801.8 ± 35.9 | 268.9 ± 14.9 | 793.0 ± 40.1 |
10S | 891.8 ± 21.9 | 151.3 ± 3.9 | 901.1 ± 15.1 | 938.2 ± 20.1 | 366.5 ± 17.3 | 961.2 ± 40.8 |
10N | 831.3 ± 19.6 | 160.8 ± 31.7 | 864.9 ± 18.6 | 882.9 ± 17.8 | 229.6 ± 13.8 | 923.3 ± 25.3 |
Suppl. form effect | ||||||
Nanoparticles | 873.2 ± 12.8 | 150.3 ± 10.3 | 895.5 ± 10.2 | 859.9 ± 25.9 | 322.6 ± 18.7 | 874.4 ± 30.4 |
Standard | 888.6 ± 9.4 | 140.3 ± 3.4 | 906.7 ± 7.9 | 901.5 ± 24.5 | 346.0 ± 16.1 | 900.6 ± 31.2 |
Dose effect | ||||||
100% | 889.8 ± 11.5 | 135.9 ± 3.7 | 909.4 ± 8.5 | 902.4 ± 34.8 | 371.7 a ± 21.8 | 916.8 a,b ± 35.9 |
50% | 891.3 ± 9.7 | 143.8 ± 4.5 | 910.9 ± 9.0 | 829.2 ± 33.6 | 278.2 b ± 13.7 | 803.4 b ± 34.1 |
10% | 861.6 ± 17.8 | 156.1 ± 14.9 | 883.0 ± 13.5 | 910.4 ± 16.2 | 353.1 a ± 11.4 | 942.3 a ± 23.4 |
p-value | ||||||
Source of variation | ||||||
Suppl. Form | 0.3 | 0.38 | 0.37 | 0.25 | 0.24 | 0.51 |
Dose | 0.19 | 0.36 | 0.13 | 0.14 | 0.0024 | 0.02 |
Suppl. form × Dose | 0.11 | 0.99 | 0.33 | 0.86 | 0.98 | 0.98 |
* 100S: 100% of the dose in a standard form; 100N: 100% of the dose in a nanoparticle form; 50S: 50% of the dose in a standard form; 50N: 50% of the dose in a nanoparticle form; 10S: 10% of the dose in a standard form; 10N: 10% of the dose in a nanoparticle form; a,b Means in the same column with different letters are significantly different (p < 0.05) separately between the group, between the species and between the additives.